Sanofi And Selecta To Partner On Immunotherapies For Life-Threatening Allergies
This article was originally published in The Pink Sheet Daily
Executive Summary
Vaccine and immunotherapy-focused Selecta, up to now focused on grants for funding, signs its first big pharma partner around targeted, antigen-specific programs for undisclosed allergies.